Triprolidine: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
m Protected "Triprolidine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
(No difference)
|
Revision as of 18:58, 27 September 2011
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 4% oral |
Protein binding | 90% |
Metabolism | Hepatic (CYP2D6) |
Elimination half-life | 4 to 6 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C19H22N2 |
Molar mass | 278.391 g/mol |
3D model (JSmol) | |
Melting point | 60 °C (140 °F) |
Solubility in water | 500 mg/mL (20 °C) |
|
WikiDoc Resources for Triprolidine |
Articles |
---|
Most recent articles on Triprolidine Most cited articles on Triprolidine |
Media |
Powerpoint slides on Triprolidine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Triprolidine at Clinical Trials.gov Clinical Trials on Triprolidine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Triprolidine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Triprolidine Discussion groups on Triprolidine Patient Handouts on Triprolidine Directions to Hospitals Treating Triprolidine Risk calculators and risk factors for Triprolidine
|
Healthcare Provider Resources |
Causes & Risk Factors for Triprolidine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Triprolidine hydrochloride is an over-the-counter antihistamine. It is used to combat the symptoms associated with allergies and is sometimes combined with other cold medications designed to provide general relief for flu-like symptoms. Like many over-the-counter antihistamines, the most common side effect is drowsiness.
Trade names
- Actidil
- Myidil
- Actifed (as a combination with pseudoephedrine) - no longer contains pseudoephedrine or triprolidine as of the end of 2006.
External links
- Pages with script errors
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Antihistamines